Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
3.535
-0.005 (-0.14%)
Jan 23, 2025, 1:47 PM EST - Market open
Cardiff Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 23, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 235 | 66 | 63 | 252 | 635 | 10 | |
| Market Cap Growth | 100.14% | 5.71% | -75.20% | -60.31% | 6519.33% | -20.54% | |
| Enterprise Value | 180 | -13 | -49 | 121 | 600 | 2 | |
| Last Close Price | 3.54 | 1.48 | 1.40 | 6.01 | 17.99 | 1.24 | |
| PS Ratio | 232.91 | 135.50 | 162.04 | 702.51 | 1736.31 | 39.24 | |
| PB Ratio | 3.49 | 0.95 | 0.59 | 1.80 | 4.96 | 1.31 | |
| P/TBV Ratio | 2.52 | 0.95 | 0.59 | 1.80 | 4.96 | 1.31 | |
| EV/Sales Ratio | 260.92 | - | - | 338.28 | 1640.66 | 10.20 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | 0.24 | |
| Asset Turnover | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| Quick Ratio | 4.65 | 7.19 | 13.58 | 21.55 | 21.46 | 2.17 | |
| Current Ratio | 4.74 | 7.41 | 14.25 | 22.28 | 21.79 | 2.37 | |
| Return on Equity (ROE) | -67.57% | -47.07% | -31.37% | -21.07% | -28.50% | -188.72% | |
| Return on Assets (ROA) | -38.33% | -28.69% | -18.77% | -12.69% | -16.14% | -76.48% | |
| Return on Capital (ROIC) | -44.22% | -31.37% | -19.75% | -13.23% | -17.28% | -109.03% | |
| Earnings Yield | -18.26% | -62.67% | -61.88% | -11.22% | -3.04% | -170.97% | |
| FCF Yield | -14.71% | -47.59% | -55.68% | -9.22% | -2.60% | -138.90% | |
| Buyback Yield / Dilution | -1.40% | -2.47% | -11.71% | -86.97% | -249.44% | -156.37% | |
| Total Shareholder Return | -1.40% | -2.47% | -11.71% | -86.97% | -249.44% | -156.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.